BRCA1/2 Pathway and Hematologic Cancers
Author Information
Author(s): Friedenson Bernard
Primary Institution: Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago
Hypothesis
Inactivation of virtually any component within the pathway containing the BRCA1 and BRCA2 proteins would increase the risks for lymphomas and leukemias.
Conclusion
The BRCA pathway is essential to prevent a subgroup of human leukemias and lymphomas that may involve non-random, characteristic gene rearrangements.
Supporting Evidence
- Deleterious mutations of genes in the BRCA pathway increased risks up to nearly 2000 fold for certain leukemias and lymphomas.
- Mantle cell lymphoma is associated with a characteristic rearrangement of DNA fragments between chromosomes 11 and 14.
- Meta-analysis showed strong odds ratios for an ATM-MCL association across multiple studies.
Takeaway
The BRCA1 and BRCA2 proteins help prevent certain blood cancers, and if they don't work properly, the risk of these cancers goes way up.
Methodology
Literature searches and meta-analyses of epidemiology and basic science articles related to the BRCA pathway were conducted.
Potential Biases
Potential bias due to the rarity of mutations in some molecules and reliance on existing literature.
Limitations
Access to original data is limited, and some studies may not provide required data for analysis.
Participant Demographics
The study included data from various epidemiological studies over the past 20 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI = 34.59–142.72
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website